Literature DB >> 9372774

Natural history and treatment outcomes of childhood hip disorders.

S L Weinstein1.   

Abstract

Normal hip joint growth and development occur as a result of a genetically determined balance of growth of the acetabular and triradiate cartilages and the presence of a well located centered spheric femoral head. The majority of acetabular development is determined by age 8 years. This is a watershed age for prognosis in many pediatric hip disorders. Hip joint growth and development and how these are affected by the disease process and treatment interventions profoundly affect outcome. Outcomes of these disease processes (congenital hip dislocation and dysplasia, Legg-Calvé-Perthes disease and slipped capital femoral epiphysis), is multifactorial but profoundly influenced by the age at the disease onset (birth to the adolescent growth spurt), and the effects of treatment on the relationship between femoral head and acetabular development. The natural history of many of these childhood hip disorders is the development of degenerative joint disease. Degenerative joint disease and clinical disability may develop in these conditions despite standard up to date treatment interventions. In most of the hip diseases discussed, patients usually do well clinically for many years regardless of treatment.

Entities:  

Mesh:

Year:  1997        PMID: 9372774

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  20 in total

1.  Clinical stability of slipped capital femoral epiphysis does not correlate with intraoperative stability.

Authors:  Kai Ziebarth; Stephan Domayer; Theddy Slongo; Young-Jo Kim; Reinhold Ganz
Journal:  Clin Orthop Relat Res       Date:  2012-04-10       Impact factor: 4.176

2.  Inter-observer reliability of the Stulberg classification in the assessment of Perthes disease.

Authors:  Ola Wiig; Terje Terjesen; Svein Svenningsen
Journal:  J Child Orthop       Date:  2007-04-28       Impact factor: 1.548

3.  The long-term prognosis of Legg-Calvé-Perthes disease: a historical prospective study with a median follow-up of forty one years.

Authors:  Nicole Heesakkers; Robin van Kempen; Rhijn Feith; Jan Hendriks; Wim Schreurs
Journal:  Int Orthop       Date:  2014-11-19       Impact factor: 3.075

4.  Extent of physeal involvement in Legg-Calvé-Perthes disease.

Authors:  Kwang-Won Park; Chastity Amor Rejuso; Rey-An Nino Garcia; Tae-Wan Kim; Hae-Ryong Song
Journal:  Int Orthop       Date:  2014-08-17       Impact factor: 3.075

5.  Outcome after early mobilization following hip reconstruction in children with developmental hip dysplasia and luxation.

Authors:  Katharina Susanne Gather; Eva von Stillfried; Sebastien Hagmann; Sebastian Müller; Thomas Dreher
Journal:  World J Pediatr       Date:  2018-02-20       Impact factor: 2.764

6.  Legg-Calvé-Perthes disease: role of isolated adductor tenotomy?

Authors:  Joaquín Moya-Angeler; Juan Carlos Abril; Ignacio Varo Rodriguez
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-10-30

7.  High survival of dome pelvic osteotomy in patients with early osteoarthritis from hip dysplasia.

Authors:  Takashi Sakai; Takashi Nishii; Masaki Takao; Kenji Ohzono; Nobuhiko Sugano
Journal:  Clin Orthop Relat Res       Date:  2012-02-22       Impact factor: 4.176

8.  [The natural history of developmental dysplasia of the hip. A meta-analysis of the published literature].

Authors:  J Ziegler; F Thielemann; C Mayer-Athenstaedt; K-P Günther
Journal:  Orthopade       Date:  2008-06       Impact factor: 1.087

9.  Early clinical and radiological outcomes after double osteotomy in patients with late presentation Legg-Calvé-Perthes disease.

Authors:  Carlos A Sarassa; Ana Milena Herrera; Jaime Carvajal; Luisa F Gomez; Camilo A Lopez; Andres F Rojas
Journal:  J Child Orthop       Date:  2008-09-24       Impact factor: 1.548

10.  Treatment of severe late-onset Perthes' disease with soft tissue release and articulated hip distraction: revisited at skeletal maturity.

Authors:  Eitan Segev; Eli Ezra; Shlomo Wientroub; Moshe Yaniv; Shlomo Hayek; Yoram Hemo
Journal:  J Child Orthop       Date:  2007-09-27       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.